2018
DOI: 10.1016/j.acra.2017.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Sonographic Criteria Predictive of Malignant Thyroid Nodules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 21 publications
0
4
0
1
Order By: Relevance
“…No significant evidence currently exists for any single characteristic. Clinically, it usually defines the risk according to the number of ultrasound features, which has great uncertainty (Oliveira et al, 2018). The European Thyroid Association Guidelines for ultrasound malignancy risk stratification (EU-TIRADS) suggested that the numbers of high-risk features including ECHO, TTW, IRE, EF, and ITC from 1 to > −4 could indicate the risk form 5 to 80%.…”
Section: Introductionmentioning
confidence: 99%
“…No significant evidence currently exists for any single characteristic. Clinically, it usually defines the risk according to the number of ultrasound features, which has great uncertainty (Oliveira et al, 2018). The European Thyroid Association Guidelines for ultrasound malignancy risk stratification (EU-TIRADS) suggested that the numbers of high-risk features including ECHO, TTW, IRE, EF, and ITC from 1 to > −4 could indicate the risk form 5 to 80%.…”
Section: Introductionmentioning
confidence: 99%
“…En este estudio se presentaron dos hallazgos como los mejores predictores de malignidad, el primero: las adenopatías asociadas al igual que el estudio realizado por Oliveira, et al 19 Según autores las metástasis ganglionares regionales del cuello están presentes hasta en el 50-70 % de los casos de malignidad, incluidas aquellas metástasis microscópicas halladas en la histología, por lo tanto, puede considerarse como una situación frecuente. Según Mac Dermott, et al el compromiso ganglionar no es considerado un factor de riesgo importante de mortalidad, excepto en pacientes mayores de 45 años, en quienes su presencia sí modifica la estadificación de riesgo de mortalidad, tratamiento y seguimiento 20 .…”
Section: Discussionunclassified
“…The halo sign is a nonspecific manifestation of a mummified nodule. Experts have differing opinions regarding the value of the halo sign in distinguishing benign from malignant nodules [10][11][12][13][14]. Lacout et al [6] considered that the halo sign is related to the development of tissue granulation and the formation of a fibrous capsule.…”
Section: Discussionmentioning
confidence: 99%